Tetsuo Sakai

Tetsuo Sakai

Auto-generated profile, based on publicly available information

Tetsuo Sakai

Department of Neurology, National Chikugo Hospital, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2001 in European Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
TST. Sakai
T. Sakai
AWA. Wakizaka
A. Wakizaka
YNY. Nirasawa
Y. Nirasawa
Three cases of congenital central hypoventilation syndrome (CCHS) associated with Hirschsprung's disease (HSCR) were examined with respect to their genomic DNA on the coding region of the receptor tyrosine kinase (RET) and the endothelin-B receptor (EDNRB). No causative mutations for the disease were detected, but one polymorphism was observed in exon 11 of the RET proto-oncogene. In cases with CCHS, HSCR occurs with a high incidence, and this disease complex has been described as neurocristopathy due to aberrations in neural crest cell proliferation, differentiation or migration during the early fetal period. Both the RET and EDNRB may play important roles in the modulation of neurocristopathies; however, further systemic studies in a large population of patients and control subjects are necessary for elucidating the pathogenesis of this disorder. Trois cas de syndrome d'hypoventilation congénitale centrale (CCHS), associés à une maladie de Hirschsprung (HSCR) ont eu une étude de leur génome DNA sur la région codante pour le récepteur à la tyrosine kinase (RET) et le récepteur à l'endothéline B (EDNRB). Aucune mutation responsable n'était mise en évidence, mais un polymorphisme était observé sur l'exon 11 du proto-oncogène RET. En cas de CCHS, HSCR survient avec une grande fréquence et cette maladie complexe a été décrite comme neurocristopathie secondaire à des aberrations de la prolifération, de la différenciation ou de la migration des cellules de la crête neurale survenant précocement pendant la vie fœtale. Tout à la fois le RET et le EDNRB peuvent jouer un rôle important dans la survenue des neurocristopathies, toutefois, des études ultérieures sur un large échantillon de patients ou de témoins sont nécessaires pour élucider la pathogénie de ce désordre. Se estudió el DNA genómico de 3 casos de síndrome de hipoventilación central congénita (CCHS) asociada a enfermedad de Hirschsprung (HSCR) en la región de codificación del receptor de la tirosin-kinasa (RET) y del receptor de la endotelina B (EDNRB). No se encontraron mutaciones causantes de enfermedad pero se observó un polimorfismo del exón 11 de proto-oncogén RET. En casos con CCHS, se observa la enfermedad de Hirschsprung con una incidencia alta y este complejo patológico ha sido interpretado como una neurocristopatía debida a aberraciones de la proliferación de células de la cresta neural, de la diferenciación o de la migración de estas durante el periodo fetal inicial. Tanto el RET como el EDNRB pueden jugar papeles importantes en la modulación de las neurocristopatías. Sin embargo, son necesarios más estudios sistémicos en poblaciones mayores de pacientes y en sujetos control para elucidar la patogenia de estos transtornos. Es werden 3 Fälle eines angeborenen Hypoventilationssyndroms (Ondine-Syndrom) in Verbindung mit Morbus Hirschsprung vorgestellt. Bei allen Patienten wurden die Genom-DNA sowie der Kodierungsort der Receptor tyrosine kinase (RET) und der Endothelin-B-Rezeptor (EDNRB) untersucht. Es wurde keine Erkrankung, die zu Mutationen hätte führen können, beobachtet, jedoch ein Polymorphismus im Exon 11 des RET Protoonkogens. Ein zentrales, angeborenes Hypoventilationssyndrom (Ondine-Syndrom) ist sehr häufig mit einem Megakolon congenitum Hirschsprung verbunden. Die Ursache dieses Syndroms ist eine Neurokristopathie infolge von Abweichungen in der Proliferation neuraler Stammzellen, ihrer Differenzierung oder Wanderung in der frühen Fetalperiode. Sowohl RET Proto-onkogen wie EDNRB spielen eine wichtige Rolle in der Modulation von Neurokristopathien. Es sind jedoch weitere systemische Studien in einer größeren Population von Patienten notwendig, um die Pathogenese dieses Syndromenkomplexes zu erhellen.

1 June 1994 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
HTHiroshi Takashima
Hiroshi Takashima
TSTetsuo Sakai
Tetsuo Sakai
HIHiroshi Iwashita
Hiroshi Iwashita
YMYuki Matsuda
Yuki Matsuda
KTKaoru Tanaka
Kaoru Tanaka
MRMarion E. Reid
Marion E. Reid

1 January 1996 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
TSTetsuo Sakai
Tetsuo Sakai
TITakeshi Ishizaki
Takeshi Ishizaki
TNTsuguhiko Nakai
Tsuguhiko Nakai
SMSusumu Miyabo
Susumu Miyabo
SMShigeru Matsukawa
Shigeru Matsukawa
TOTakayuki Ozawa
Takayuki Ozawa

1 September 1995 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
TST. Sakai
T. Sakai
TIT. Ishizaki
T. Ishizaki
TOT. Ohnishi
T. Ohnishi
FSF. Sasaki
F. Sasaki
SAS. Ameshima
S. Ameshima
TOT. Ozawa
T. Ozawa
To investigate how mitochondrial function was affected in leukotoxin (Lx)-,9,10-epoxy-12-octadecenoate-induced lung injury, lung mitochondria were extracted from isolated perfused rat lung with or without Lx-induced edematous injury. In the lung treated with 30 mumol of Lx, the mitochondrial respiration rate in states 3 and 4 significantly decreased (without mitochondrial uncoupling) concomitantly with increased release of lactate dehydrogenase (LDH), a parameter for cellular damage, into the perfusate and decreased ATP content in the lung tissue compared with those of untreated lung. Moreover, 30 mumol of Lx resulted in significant inhibition of cytochrome-c oxidase activity (vs. vehicle control). In contrast, lower doses of Lx (10 mumol) caused lung edema and cellular damage without evidence for mitochondrial dysfunction. We also examined cellular and mitochondrial damage in hydrostatic lung edema. Such edema showed neither suppressed mitochondrial respiration nor elevated LDH activity in perfusate, although lung wet weight increased as much as it did after 30 mumol Lx treatment. Our results suggest that the ex vivo mitochondrial dysfunction is one of the secondary (vs. initial augmented permeability) but specific manifestations of toxicity of Lx, and together with the previous reports, the ex vivo damaging effect of Lx against mitochondria may be ascribed not to its direct action on mitochondria but to Lx-derived cellular mechanism(s).

1 July 1991 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
YAYasunobu Antoku
Yasunobu Antoku
FKFumihiko Koike
Fumihiko Koike
YOYachiyo Ohtsuka
Yachiyo Ohtsuka
TSTetsuo Sakai
Tetsuo Sakai
KTKohsuke Tsukamoto
Kohsuke Tsukamoto
IGIkuo Goto
Ikuo Goto

29 October 2020 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
MNMiyako Nagumo
Miyako Nagumo
TSTakashi Saito
Takashi Saito
TSTetsuo Sakai
Tetsuo Sakai
SIShiro Iwanaga
Shiro Iwanaga
An 85-year-old woman presented with anorexia, general fatigue, and cold extremities. She had no history of chest pain. Her blood pressure was 74/62 mmHg, and SpO2 was 86%. V-wave was observed in her jugular vein. A pan-systolic murmur with Levine grade 3/6 at the left sternal border of the fourth intercostal space. Electrocardiography revealed ST elevation in V2 to V4 and QS pattern in V1 to V3. Her creatinine level was 1.58 mg/dL (range: 0.37–0.84 mg/dL), and urea nitrogen was 87 mg/dL (range: 10–24 mg/dL). Transthoracic echocardiography revealed dyskinesis of the apex and ventricular septal perforation (VSP) with bidirectional shunt. Left ventricular (LV) ejection fraction was 58%. The anterior tricuspid leaflet was flail due to papillary muscle rupture (PMR), resulting in severe tricuspid regurgitation (Figure 1 and Videos 1 and 2). These findings suggested acute myocardial infarction (MI) and cardiogenic shock with multiorgan failure.